mRNA Vaccines Market Report 2021-2031

Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement, Other), by End-user (Hospitals and Clinics, Research Organizations, Other End-user), by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines, Other Vaccine Types).

Lyon, FRANCE


New York, April 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "mRNA Vaccines Market Report 2021-2031" - https://www.reportlinker.com/p06058579/?utm_source=GNW
Plus Analysis of Leading Regional and National Markets and Analysis of Leading mRNA Companies

mRNA vaccines are key in this COVID-19 pandemic situation?
Vaccines are crucial now. The race for a COVID-19 vaccine is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. The ability to mimic the natural viral infection and therefore produce the antigen proteins from within the cell is seen by many as the best form of protection from this novel coronavirus.

But this isn’t the only mRNA vaccine being developed. Other key vaccines areas such as cancer, respiratory illness, and HIV etc. are essential opportunities within mRNA vaccine development.

You need to discover how this will impact the market today, and over the next 10 years:
• Our in-depth, dedicated 460+-page report contains more than 650 tables and diagrams.
• Delivers best-benefit areas for short- to long-term mRNA vaccine and future prospects
• Analyses, for you, global, regional and national sales
• Highlights successful results, trends, changes and revenue projections
• Tells you how to profit best from mRNA vaccines today.

This report tells you:
• How key players in the mRNA market are strategically increasing/ decreasing/ holding their positions?
• What are the funding trends in the mRNA vaccines market?
• Development scenarios and global confidence regarding mRNA vaccines
• Technological and structural changes occurring in the vaccine industry and how they effect you
• Growth assessments within the mRNA vaccines industry during the forecast timeline?

This report is not available to everyone. Just a few of these reports exist. Make sure you get your copy immediately.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

The emergence of a mRNA Vaccine
The mRNA vaccine market is constantly thriving to improve vaccine efficiency and provide better protection each season. Is this possible? Pharma companies tackle novel approaches to vaccine technology, better administration and delivery, plus production of the vaccine. Never has this been more critical – yet never before has it offered you such opportunity for development.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares of your main competitors.
• Original analyses – this is not available anywhere else
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Product Pipeline Analysis, product profiles and commercial developments.

UNIQUE COVID-19 VARIATIONS – only available in this this report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 effects the economy.

Discover sales predictions for the world market and submarkets

By Treatment Type
• Bioengineered Vaccine
• Gene Therapy
• Gene Transcription
• Cell Therapy
• Monoclonal Antibody
• Immune System
• Other Treatment Type

By Type mRNA Vaccines
• Non-replicating mRNA
• In-vivo Self-replicating mRNA
• In-vitro Non-replicating mRNA
• Other mRNA Type

By Application
• Cancer
• Infectious Disease
• Gene Editing
• Protein Replacement
• Other

By End-User
• Hospitals and Clinics
• Research Organizations
• Other End-User

By Vaccine Type
• Self-amplifying mRNA-based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines
• Other Vaccine Types

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential. These technologies are the instruments required for the marketing of mRNA vaccines to achieve higher efficacy in people.

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

• North America:
• U.S.
• Canada

• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

• Asia Pacific:
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa:
• Turkey
• Saudi Arabia
• Iran
• South Africa
• UAE
• Rest of Middle East & Africa

How the mRNA Vaccines Market report helps you?
In summary, our 460+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for mRNA Vaccines Market, forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 14 key national markets – See forecasts for the mRNA Vaccines market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the mRNA Vaccines Market.
• AstraZeneca PLC
• Bausch Health Companies Inc.,
• Bayer Inc.
• Eli Lilly and Company
• Roche Holding AG (Roche)
• Genentech, Inc.
• Merck & Co., Inc.
• Metropolis Healthcare Limited
• Moderna, Inc.
• Mymetics Corporation
• Ligand Pharmaceuticals Incorporated (Ligand)
• Pfizer Inc. (Pfizer)
• Sanofi
• Vertex Pharmaceuticals Incorporated
• Virbac Pharmaceutical

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the mRNA Vaccines Market and leading companies. You will find data, trends and predictions.
Read the full report: https://www.reportlinker.com/p06058579/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

Contact Data